Alexza Announces Adasuve Staccato (Loxapine) PDUFA Goal Date of February 4, 2012
Links shared publicly online about this topic.
- 48total visits
Alexza Announces Adasuve Staccato (Loxapine) PDUFA Goal Date of February 4, 2012
Adasuve (loxapine) is a new drug in development for the treatment of agitation in adults with schizophrenia or bipolar disorder. Adasuve information includes news, clinical trial results and side effects.
View full resource at drugs.com
Tags: Bipolar Disorder, Schizophrenia, Psychotic Disorder, Disease and Condition, Drug, News, Nature
Most Recently Shared on August 25, 2011 at 1:18 am By:
Alexza Announces Adasuve Staccato (Loxapine) PDUFA Goal Date of February 4, 2012: MOUNTAIN VIEW, Calif., A... http://t.co/aym2Xh8 #drug
Alexza Announces Adasuve(TM) (Staccato® Loxapine) PDUFA Goal Date of February 4, 2012 - MarketWatch
marketwatch.com — “Alexza Announces Adasuve(TM) (Staccato® Loxapine) PDUFA Goal Date of February 4, 2012 - MarketWatch” View full resource at marketwatch.com
Most Recently Shared on August 19, 2011 at 2:08 pm By:
Peter H Brown Doctor and Psychologist
Alexza Announces Adasuve(TM) (Staccato® Loxapine) PDUFA Goal Date of February ... http://t.co/3ssUlkU #bipolar
Advertisement
